$OMER nicotine addiction may have been the fastest route to approval , but how would stock have reacted during this opioid crisis if we found a partner to go after after opioid addiction and completed phase 1? And is PPS realy better of by not diluting to go after this indication and losing 5 years of potential revenue while it sits there waiting till we have funds to start clinical trials?
  • 17
  • 1